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A key prerequisite to understand how gene regulatory processes are controlled by the interplay of RNA-
binding proteins and ribonucleoprotein complexes with RNAs is the generation of comprehensive high-
resolution maps of protein–RNA interactions. Recent advances in next-generation sequencing technology
accelerated the development of various crosslinking and immunoprecipitation (CLIP) approaches to
broadly identify RNA regions contacted by RNA-binding proteins. However these methods only consider
single RNA-binding proteins and their contact sites, irrespective of the overall cis-regulatory sequence
space contacted by other RNA interacting factors. Here we describe the application of protein occupancy
profiling, a novel approach that globally displays the RNA contact sites of the poly(A)+ RNA-bound pro-
teome. Protein occupancy profiling enables the generation of transcriptome-wide maps of protein–RNA
interactions on polyadenylated transcripts and narrows the sequence search space for transcript regions
involved in cis-regulation of gene expression in response to internal or external stimuli, altered cellular
programs or disease.
 2013 The Authors. Published by Elsevier Inc. All rights reserved.1. Introduction a triple-helical RNA structure at their 30 end [13,14], while otherBesides transcriptional regulation, gene expression in higher
eukaryotes is extensively controlled and regulated at multiple
co- and posttranscriptional levels [1,2]. RNA binding proteins
(RBPs) and non-coding RNAs form dynamic ribonucleoprotein
complexes (RNPs) that control the fate of an RNA molecule
throughout its entire lifecycle and affect every aspect of RNA
metabolism ranging from splicing to cellular localization and decay
[3–5]. While RNP complexes are essential components of the splic-
ing machinery and other messenger RNA (mRNA) processing path-
ways, they appear equally important towards the physiological
function of long intervening noncoding RNAs (lincRNAs). Similar
to mRNAs, lincRNAs are abundant and stable RNA polymerase II
products that are typically capped, spliced and polyadenylated,
but lack protein coding potential and differ in primary sequence
conservation from classical mRNAs [6–11]. Experimental methods
to identify lincRNAs frequently involve poly(A)+ purification of
RNA, thus to date most annotated lincRNAs are polyadenylated
[12]. However examples of alternative 30 end topologies exist:
few lincRNAs such as the most abundant isoform of Malat1 formlincRNAs are stabilized by small nucleolar RNA (snoRNA) interac-
tions at both ends [12] or exist as circular isoforms [15,16].
LincRNAs typically engage in complex RNP networks with numer-
ous chromatin regulators, thereby influencing gene expression and
chromatin state [17–23].
In order to foster our understanding of how dynamic protein–
RNA interactions, as they occur in RNP complexes, alter gene-
expression programs, the global identification of RNA regions
bound and regulated by RBPs and other regulatory protein factors
remains a central task. Two recent studies provide compelling
evidence that the mammalian genome encodes around 800 RBPs,
potentially engaging in various RNP complexes that bind and reg-
ulate defined sequence or structural elements of polyadenylated
transcripts [24,25]. These and other studies suggest the existence
of a large number of mRNA binders with diverse molecular
functions participating in combinatorial posttranscriptional gene
expression networks [2–4]. Importantly, numerous RBPs have been
implicated in human disease and pathology and are thus subject of
active research [26,27]. Similarly, dozens of lincRNAs were shown
to have altered expression profiles in human cancers and appear to
be regulated by prominent oncogenes and tumor-supressors [23].
Accelerated by recent developments in next-generation
sequencing technology, a variety of methods for broad identifica-
tion of RBP target sites are continuously emerging. Crosslinking
and immunoprecipitation (CLIP) and its adaptations such as
High-Throughput Sequencing CLIP (HITS-CLIP), crosslinking and
analysis of cDNAs (CRAC), individual-nucleotide resolution CLIP
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(PAR-CLIP) thus far enabled the characterization of more than
three dozens of RNA-binding proteins and their target transcripts
[24,28–38]. While HITS-CLIP, CRAC, and iCLIP use high-energy
254 nm wave length UV irradiation for crosslinking, PAR-CLIP re-
lies on 365 nm UV irradiation in combination with non-perturbing
metabolic labeling of transcripts with photoreactive nucleoside
analogs, such as 4-thiouridine (4SU) to enhance crosslinking effi-
ciency [31]. One of the hallmarks of the PAR-CLIP methodology is
the occurrence of a prominent diagnostic T–C transition in cDNA
sequence reads, marking the protein–RNA crosslinking site on
the target transcript [31]. Despite every method bearing certain
advantages and limitations, all approaches share the basic princi-
ple of crosslinking a single RBP to its target regions, followed by
immunoprecipitation of the protein of interest and sequencing of
associated RNA fragments [32–34]. Thus these methods are
designed to study individual RNA binding proteins in isolation,
without considering the overall context of protein–RNA interac-
tions occurring in an expressed transcriptome at a given time.
Using photoactivatable ribonucleoside enhanced crosslinking in
combination with oligo (dT) affinity purification of polyadenylated
transcripts, we were able to globally identify RNA contact sites of
the poly(A)+ RNA-bound proteome by profiling diagnostic T–C
nucleotide transitions that occur at direct protein–RNA interaction
sites (Fig. 1) [24]. Protein occupancy profiling on polyadenylated
RNA enabled the generation of the first transcriptome-wide catalog
of potential cis-regulatory mRNA regions of a human cell line and
revealed protein–RNA contacts throughout large sequence
stretches in UTRs and coding sequences. Functional relevance of
captured interactions is supported by elevated evolutionary con-
servation and decreased single-nucleotide-polymorphism (SNP)
frequency of crosslinked nucleotides when compared to non-cross-
linked nucleotides in the same set of sequences [24].
2. Protein occupancy profiling on long noncoding and
messenger RNA protocol
2.1. Material
2.1.1. BuffersBuffer Composition4-Thiouridine stock
(1 M)260.27 mg 4-thiouridine in 1 ml H2OD-MEM growth
mediumD-MEM high glucose
10% (v/v) fetal bovine serum
2 mM L-glutamine
100 U/ml penicillin
100 U/ml streptomycinDephosphorylation
buffer50mM Tris–HCl pH 7.9 at 25 C
100 mM NaCl
10 mM MgCl2
1 mM DTTDNA loading dye (5) 0.2% (w/v) Bromophenol blue
0.2% (w/v) Xylene cyanol FF
50 mM EDTA, pH 8.0
20% (w/v) Ficoll type 400Elution buffer 10 mM Tris-HCl pH 7.5 at 25 C
Lysis/binding buffer 100 mM Tris-HCl pH 7.5 at 25 C
500 mM LiCl
10 mM EDTA pH 8.0 at 25 C
1% LiDS
add fresh: 5 mM DTT and Complete
Mini EDTA-free protease inhibitor
(Roche)(continued)Buffer CompositionNP40 washing buffer 50 mM Tris-HCl pH 7.5 at 25 C
140 mM LiCl
2 mM EDTA pH 8.0 at 25 C
0.5% NP40
add fresh: 0.5 mM DTTPCR buffer (10) 100 mM Tris–HCl pH 8.0 at 25 C
500 mM KCl
20 mM MgCl2
10 mM b-mercaptoethanol
1% (v/v) Triton X-100PNK buffer 50 mM Tris–HCl pH 7.5 at 25 C
50 mM NaCl
10 mM MgCl2
5 mM DTTProteinase K buffer 100 mM Tris–HCl pH 7.5 at 25 C
150 mM NaCl
12.5 mM EDTA
2% (w/v) SDSRNA ligase buffer with
ATP (10)500 mM Tris–HCl pH 7.5 at 25 C
100 MgCl2
10 mM DTT
10 mM ATPRNA ligase buffer
without ATP (10)500 mM Tris–HCl pH 7.5 at 25 C
100 MgCl2
10 mM DTTRNA loading buffer
(2)8 M Urea
1.5 mM EDTA
1% (w/v) Bromophenol blueSaturated ammonium
sulfate solutionAt 25 C add 766.80 g ammonium
sulfate to 1000 g H2OSDS–PAGE loading
buffer (2)100 mM Tris–HCl pH 6.8 at 25 C
200 mM DTT
4 mM EDTA
4% (w/v) SDS
20% Glycerol
0.2% (w/v) Bromophenol blueTransfer buffer 25 mM Tris–HCl pH 8.5 at 25 C
192 mM Glycine
20% (v/v) Methanol2.2. Oligo(dT) beads, enzymes and oligonucleotides
2.2.1. Oligo(dT) beadsMaterial ManufacturerDynabeads mRNA DIRECT Life Technologies2.2.2. Enzymes and other materialMaterial Manufacturer[c-32P]-ATP, 3000 Ci/mmol, 10 mCi/ml Perkin Elmer
ATP (100 mM) Fermentas
Benzonase Merck Millipore
Calf intestine alkaline phosphatase
(CIP)
New England
Biolabs(continued on next page)
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Glycoblue Ambion
NuPAGE MOPS SDS running buffer (20) Life Technologies
NuPAGE Novex 4-12% BT Midi 1.0 gel Life Technologies
NuSieve GTG agarose Lonza
Phusion high-fidelity DNA polymerase Thermo Scientific
Proteinase K Roche
ProteoSilver Silver Stain Kit Sigma-Aldrich
Protran nitrocellulose membranes Whatman
Qiaquick gel extraction kit Qiagen
RNase I Ambion
SequaGel UreaGel System National Diagnostics
Superscript III reverse Transcriptase Life Technologies
T4 polynucleotide kinase (T4 PNK) New England
Biolabs
T4 RNA ligase 2, truncated K227Q New England
Biolabs
T4 RNA-ligase 1 New England
Biolabs2.2.3. OligonucleotidesOligonucleotide Sequence50-Adapter (RNA) 50-rGrUrUrCrArGrArGrUrUrCrUr
ArCrArGrUrCrCrGrArCrGrArUrC30-Adapter NBC1
(pre-adenylated)50-AppTCTAAAATCGTATGCCGTCT
TCTGCTTG-InvdT30-Adapter NBC2
(pre-adenylated)50-AppTCTCCCATCGTATGCCGTCT
TCTGCTTG-InvdT30-Adapter NBC3
(pre-adenylated)50-AppTCTGGGATCGTATGCCGTCT
TCTGCTTG-InvdT30-Adapter NBC4
(pre-adenylated)50-AppTCTTTTATCGTATGCCGTCT
TCTGCTTG-InvdT30-Adapter NBC5
(pre-adenylated)50-AppTCTCACGTCGTATGCCGTCT
TCTGCTTG-InvdT30-Adapter NBC6
(pre-adenylated)50-AppTCTCCATTCGTATGCCGTCT
TCTGCTTG-InvdT30-Adapter NBC7
(pre-adenylated)50-AppTCTCGTATCGTATGCCGTCT
TCTGCTTG-InvdT30-Adapter NBC8
(pre-adenylated)50-AppTCTCTGCTCGTATGCCGTCT
TCTGCTTG-InvdT30 PCR primer 50-CAAGCAGAAGACGGCATACGA
50 PCR primer 50-AATGATACGGCGACCACCGAC
AGGTTCAGAGTTCTACAGTCCGA2.3. Procedure
2.3.1. Cell culture and UV-crosslinking
Protein occupancy profiling is readily applicable to a variety of
cellular systems and experimental conditions. We successfully
used the described procedure to profile the protein occupancy on
polyadenylated transcripts in HEK293, HeLa, MCF7, HUVEC and
mouse embryonic stem cells. Critical to the success of the experi-
ment is the efficient incorporation of the photoreactive nucleoside,
4-thiouridine, into nascent cellular RNAs. We recommend testing
labeling efficiencies and compare it to 4SU incorporation rates ob-
served in HEK293 cells by thiol-specific biotinylation and dot blot
assay [39] or LC-MS analysis [40]. In HEK293 cells, 4SU substitution
rates between 1% and 4% yield sufficient protein–RNA crosslinkingto characterize global binding preferences of RNA binding proteins
[31,33].
Cells are grown in D-MEM high glucose growth medium and ex-
panded to 15 cm tissue culture plates. Typically five 15 cm tissue
culture plates (108 cells) are labeled at 80% confluency with
100 lM 4SU for 12–16 h. If desired an optional 100 lM 4SU label-
ing pulse can be performed shortly before harvesting (1–2 h) to en-
sure labeling of short lived transcripts. To induce formation of a
covalent bond between 4SU labeled RNA and bound proteins, cul-
ture media is removed and cells are crosslinked with 365 nm UV
light (0.2 J/cm2) on ice using a Stratalinker 2400 (Stratagene)
[41]. Crosslinked cells are scraped off with a rubber policeman
and collected by centrifugation (235 RCF, 4 C, 5 min). The cell pel-
let is washed twice with ice-cold PBS followed by centrifugation
and flash-freezing of collected cells in liquid nitrogen for long-term
storage (alternatively proceed to Section 2.3.2 immediately).
2.3.2. Preparation of cell lysate and affinity purification of mRNA
Cells are lysed in 10 pellet volumes of lysis/binding buffer by
gentle pipetting and incubation at room temperature for 10 min.
Genomic DNA is sheared by passing the lysate 6 times through a
21 gauge needle. The desired volume of oligo (dT) Dynabeads is
briefly washed in 1 ml lysis/binding buffer. For five 15 cm tissue
culture plates, an equivalent of 2 ml Dynabead suspension, as sup-
plied by the manufacturer (concentrated bed volume 15 ll), is
added to cell lysates and incubated for 1 h at room temperature
on a rotating wheel. Following incubation, beads are concentrated
on a magnet and supernatant is stored on ice for multiple rounds
of oligo (dT) affinity purification. Beads are washed three times in
10 pellet volumes of lysis/binding buffer, containing 1% lithium
dodecyl sulfate (LiDS) to ensure stringent isolation of protein-
mRNA complexes. Note that decreasing LiDS concentrations can im-
prove yields, but might reduce specificity. Beads are subsequently
washed three additional times in 10 pellet volumes of NP40 wash-
ing buffer and crosslinked poly(A)+ RNA–protein complexes are
heat-eluted in 200–500 ll low-salt elution buffer by a 2 min incu-
bation at 80 C. Eluate is placed on ice and beads are re-incubated
with lysate for a total number of 3 oligo (dT) hybridizations, repeat-
ing the described procedure. Eluates are combined and stored at
80 C or subjected to nuclease treatment (see Section 2.3.3).
From 108 crosslinked cells, we typically obtain 10–30 lg of
poly(A)+ purified RNA. Note that we did not evaluate the minimal
RNA concentration necessary for successful experiments. To con-
trol for efficient protein–RNA crosslinking and specific enrichment
of mRNA bound proteins in oligo (dT) precipitates, 20 ll of the
eluate are incubated with with RNase I (10 U/ml) and Benzonase
(125 U/ml) for 2 h at 37 C in elution buffer containing 1 mM
MgCl2. Following RNA digestion, proteins are analyzed by SDS–
PAGE. Fig. 2 shows a representative silver stained SDS–PAGE gel
of three sequential oligo (dT) purifications with and without
365 nm UV crosslinking. A defined pattern of protein bands in all
three elutions (E1–E3) indicates specific isolation of RNA bound
proteins. Multiple rounds of poly(A)+ RNA depletion by oligo (dT)
affinity purification are beneficial to increase the yield of lowly ex-
pressed transcripts or transcripts with short poly(A) tails and their
bound proteins. However, the amount of co-purifying contaminat-
ing RNA species such as ribosomal RNA increases with each addi-
tional hybridization. We found that three consecutive oligo (dT)
affinity purifications yield 80–90% of mRNA mapping sequence
reads after following the subsequently described procedures [24].
2.3.3. Nuclease treatment and isolation of protein protected mRNA
fragments
To generate protein protected RNA fragments of 20–60 nucleo-
tides (nts) in length, RNase I (100 U/ll) is added to eluates at a
dilution of 1:1000–1:5000 and samples are incubated 10 min at
Fig. 1. Graphical representation of the protein occupancy profiling methodology. Culture media is supplemented with 4SU, which is taken up by cells and incorporated into
nascent transcripts. UV irradiation at 365 nm induces covalent photocrosslinking between 4SU labeled RNA and associated RBPs. Following crosslinking, polyadenylated
transcripts are purified using oligo (dT) beads, protein protected RNA fragments are generated by RNase I digestion and proteins are removed by proteinase K treatment. RNA
fragments are converted into a cDNA library and next-generation sequenced. Mapping of sequencing reads to the respective reference sequence reveals diagnostic T–C
transitions as a signature of protein–RNA crosslinking. T–C transitions are used to globally profile protein interaction sites across the transcriptome.
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RNase treatment in pilot experiments is recommended. Use of
RNase I does not introduce a nucleotide bias [42]. Following incu-
bation, 4 volumes of saturated ammonium sulfate solution are
added and samples are incubated 30 min on ice for precipitation.
We found that salting out with ammonium sulfate is superior to
other protein precipitation methods (e.g. ethanol or trichloroacetic
acid precipitation), as it efficiently removes non-protein bound
RNA from the sample. Note that the presence or absence of diag-
nostic T–C transitions, as a signature of protein–RNA crosslinking
will be used during data analysis to discriminate crosslinked from
non-crosslinked RNA sequences.
Precipitated protein–RNA complexes are collected by centrifu-
gation (20,000 RCF, 4 C, 30 min) and supernatant is removed care-
fully. Resulting protein pellets are air-dried, resuspended in a
desired volume of SDS-loading buffer and denatured for 3 min at
95 C. Protein–RNA complexes are separated on a NuPAGE Novex
4–12% BT Midi 1.0 gel and transferred to a nitrocellulose mem-
brane (1 h at 20 V) to further remove non-protein bound RNA. Pro-
tein-containing lanes are excised and sliced membrane pieces are
incubated in 1 proteinase K buffer containing 4 mg/ml proteinase
K for 30 min at 55 C. RNA is recovered by phenol/chloroform
extraction and ethanol precipitation.Fig. 2. Oligo (dT) affinity purification of crosslinked protein–RNA complexes. Silver-
stained SDS–PAGE gel of representative experiment is shown. 20 ll of oligo (dT)
affinity purified 4SU labeled RNA with or without 365 nm crosslinking were treated
with RNase I (10 U/ml) and Benzonase (125 U/ml) for 2 h at 37 C. Proteins were
analyzed by SDS–PAGE and gel was silver stained. E1–E3 represents elutions 1–3 of
crosslinked protein–RNA complexes, respectively. Elution E1 of non-crosslinked
polyA+ RNA is shown as negative control.2.3.4. Generation of adapter ligation compatible, radiolabeled RNA
fragments
RNase I treated protein protected RNA fragments carry 50 hydro-
xyl groups and 30monophosphate termini, which require conversion
into 50 phosphates and 30 hydroxyl groups prior to adapter ligation,respectively. Following ethanol precipitation, recovered RNA frag-
ments are re-hydrated in 42.5 ll H2O and 5 ll 10 dephosphoryla-
tion buffer. Calf intestinal alkaline phosphatase is added to a final
concentration of 0.5 U/ll and reaction is incubated 30 min at
Fig. 3. Small RNA cloning of protein protected RNA fragments from two biological
replicate experiments in HEK293 cells. (A) Autoradiogram of 30 adapter ligated RNA
fragments separated on a 15% denaturing polyacrylamide urea gel. RNase I
treatment generates fragments of 20–60 nt in length (unligated RNA). Upon ligation
of the 29 nt 30 adapter, the majority of RNA shifts to a 50–100 nt size range. The RNA
population migrating between 50 and 77 nt size markers is excised from gel and
subjected to 50 ligation. Numbers 1 and 2 indicate different biological replicate
experiments. (B) Autoradiogram of 30 and 50 adapter ligated RNA fragments
separated on a 12% denaturing polyacrylamide urea gel. Ligation of the 27 nt 50
adapter leads to a size shift of 30 ligated RNA fragments. The RNA population
migrating between 74 and 103 nt size markers is excised from gel and reverse-
transcribed. Numbers 1 and 2 indicate different biological replicate experiments.
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nol precipitated and collected by centrifugation. Recovered RNA is
prepared for radiolabeling at the 50 end by re-hydrating in 39.8 ll
H2O, 0.2 ll [c-32P]-ATP (0.2 lCi/ll final) and 5 ll 10x PNK buffer.
T4 PNK is added to a final concentration of 1 U/ll. After 30 min of
incubation at 37 C, non-radioactive ATP is added to a final concen-
tration of 1 mM and incubated for 5 min at 37 C to complete phos-
phorylation of RNA. Radiolabeled RNA is again phenol/chloroform
extracted, ethanol precipitated and collected by centrifugation.
2.3.5. 30 Adapter ligation
To identify the desired size population of RNA during adapter
ligation steps, radiolabeled 21 and 50 nt RNA size markers are used
as ligation controls. 40 fmol of 50-32P-labeled RNA size markers are
diluted 1:100 (in equimolar ratios) and adjusted to a volume of
6 ll. Radiolabeled RNA samples are re-hydrated in 6 ll H2O and
2 ll 10 RNA ligase buffer, 1 ll of 100 lM pre-adenylated 30 adap-
ter and 10 ll 24% PEG 8000 are added to size markers and samples.
The use of pre-adenylated adapters eliminates the need for ATP
during ligation, and thus minimizes the problem of pool RNA ade-
nylation at the 50 phosphate that can lead to circularization of RNA
fragments. We are using barcoded 30 adapters that allow multi-
plexed Illumina sequencing (see Section 2.2.3). RNA is incubated
at 95 C for 30 s to reduce secondary structure and placed on ice
immediately. 1 ll T4 RNA ligase 2, truncated K227Q is added to
each sample and ligation reaction is incubated overnight at 16 C.
The truncated K227Q version of RNA ligase 2 minimizes adenylate
transfer from the 30 adapter 50 phosphate to the 50 phosphate of
small RNA fragments and thus reduces RNA circularization. Fol-
lowing overnight incubation, one volume RNA loading buffer is
added to the samples and RNA is separated on a 15% denaturing
7.5 M urea polyacrylamide gel (75 min., 30 W), running in 1
TBE. Radiolabeled RNA is visualized by exposure to a phosphorim-
ager screen and 30 ligated size markers are used to approximate the
length of ligated RNA fragments (shown in Fig. 3 A for biological
replicate experiments). Successfully 30 ligated RNA and size mark-
ers are excised from the gel and eluted in 400 ll 0.3 M NaCl shak-
ing on a thermomixer at 1000 rpm and 4 C overnight. Following
overnight gel elution, RNA is ethanol precipitated and collected by
centrifugation.
2.3.6. 50 Adapter ligation
5 ll H2O, 2 ll 10 RNA ligase buffer with ATP, 1 ll of 100 lM 50
adapter and 10 ll 24% PEG 8000 are added to 30 ligated RNA sam-
ples and size markers. RNA is denatured at 95 C for 30 s, put on ice
and 2 ll T4 RNA ligase 1 is added to the reaction. Ligation is per-
formed for 1 h at 37 C. Following incubation, RNA is separated
on a 12% denaturing 7.5 M urea polyacrylamide gel (75 min.,
30 W) and RNA is visualized by exposure to a phosphorimager
screen. Again, 30 and 50 ligated size markers are used to approxi-
mate the length of the successfully 30 and 50 ligated RNA fragments
(shown in Fig. 3 B for biological replicate experiments). RNA
migrating at the desired size is excised from the gel and eluted
in 400 ll 0.3 M NaCl shaking on a thermomixer at 1000 rpm
and 4 C overnight. As a carrier, 1 ll 100 lM 30 PCR primer is added
to gel pieces during elution. Following overnight elution, the RNA
is ethanol precipitated and collected by centrifugation.
2.3.7. Reverse transcription and pilot PCR
To convert recovered 30 and 50 ligated RNA into a cDNA library,
RNA is taken up in 5.6 ll H2O, 4.2 ll dNTPs (2 mM each), 3 ll 5
first strand buffer and 1.5 ll 0.1 M DTT. Following a 30 s incubation
at 95 C, RNA is placed on ice for 3 min, before primer annealing is
performed at 50 C for 3 min. 0.75 ll Superscript III Reverse Trans-
criptase is added to reaction and incubated 30 min at 42 C. After
cDNA synthesis, sample volume is adjusted to 100 ll using H2O.10 ll diluted cDNA are added to 40 ll PCR mastermix (10 ll 5
Phusion buffer, 1.25 ll dNTPs (10 mM), 0.25 ll 100 lM 50 PCR pri-
mer, 0.25 ll 100 lM 30 PCR primer, 0.5 ll Phusion High-Fidelity
DNA Polymerase, 27.75 ll H2O) and subjected to PCR amplification
after activation at 94 C for 2 min using the following cycle condi-
tions: 94 C 45 s, 50 C 85 s, 72 C 60 s. To determine the number of
cycles necessary for linear amplification, 5 ll of sample are re-
moved every 2 cycles starting from cycle number 8–22. Samples
are analyzed on a 2.5% agarose gel containing 0.4 lg/ml of ethi-
dium bromide to check for linear amplification. As shown in
Fig. 4 the PCR products should appear as a single band migrating
at the expected size of 125–150 nt. In some cases a weaker band
that corresponds to adapter-dimer or template switch products
might be observed at 100 nt. Asterisks indicate the number of
PCR cycles that were used during large scale PCR amplification
(Fig. 4).
2.3.8. Final PCR amplification and purification of cDNA library
After determining the optimal cycle number for linear PCR
amplification, 30 ll cDNA are added to 120 ll PCR mastermix
(see Section 2.3.7) and split into three equal fractions of 50 ll
each. PCR amplification for all three 50 ll reactions is performed
using the same cycle conditions as described above. Following
amplification, the PCR product is ethanol precipitated and sepa-
rated on a 2.5% low melting agarose gel, containing 0.4 lg/ml of
ethidium bromide for 2.5 h at 150 V. cDNA is visualized using a
UV transilluminator and a band migrating at 125–150 nt is excised.
cDNA is purified using the Qiaquick gel extraction kit according to
the manufacturer’s instructions. cDNA is eluted in 30 ll RNase free
water and yield as well as fragment size are determined using a
Qubit flurometric quantification instrument (Life Technologies)
and Agilent Bioanalyzer DNA chip. Multiplexed cDNA libraries
are sequenced using 100 cycles on a Illumina HiSeq 2500
instrument.
Fig. 4. Small scale PCR amplification of cDNA library. Agarose gel after small scale
pilot PCR is shown. 5 ll of sample were removed at indicated cycle numbers and
analyzed on a 2.5% low melting agarose gel, containing 0.4 lg/ml of ethidium
bromide. Bands migrating between 125 and 150 bp correspond to the expected size
of the PCR product. Asterisks indicate cycle numbers chosen for large scale PCR
amplification.
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When mapping protein occupancy profiling reads obtained
from Illumina sequencing to the respective reference genome,
diagnostic T–C transitions are observed at high frequency
(sequencing read mapping statistics of representative cDNA li-
braries are provided as Supplementary Table S1). Importantly in
the absence of UV 365 nm crosslinking, 4SU labeled RNA does
not lead to significant accumulation of spontaneously occurring
T–C transitions. As shown in Fig. 5A, T–C transitions detected in
non-crosslinked 4SU labeled RNA occur at low frequency and rep-
resent only 5.15% of the T–C transition frequency that is observed
upon crosslinking. Thus the frequency of spontaneously occurring
T–C transitions is similar to the background mutation rate of
unsubstituted nucleotides in protein occupancy profiling data
(Fig. 5A). Note that the ratio of perfect matching to edited sequence
reads is reversed upon 365 nm UV irradiation, indicating effiecient
protein–RNA crosslinking. As mentioned earlier, T–C transitions
are the signature of protein–RNA crosslinking in 4SU labeled
RNA. Thus we use the consensus T–C signature observed in at least
two replicate experiments to globally profile protein–RNA interac-
tions across the entire poly(A)+ RNA transcriptome. More specifi-
cally, we use TopHat2 (version 2.06) [43,44] for spliced
alignment of strand-specific protein occupancy profiling reads to
the human reference genome sequence (hg18). Prior knowledge
on candidate splice junctions from EnsEMBL (release 54,
www.ensembl.org) is used to increase the sensitivity of the map-
ping process. We separate all reads by strand and generate two
strand-specific mpileup read coverage files with samtools (version
0.1.18, [45]). These file are subsequently used to produce a sepa-Fig. 5. T–C transition frequency in presence or absence of UV crosslinking and distributi
uniquely mapping sequence reads containing specific nucleotide mismatches in occup
(libraries 1 and 2) is compared to that of non-crosslinked 4SU labeled RNA. T–C transition
frequency that is observed upon crosslinking. T–C mismatches are the signature of efficie
different transcript and genomic regions shown for occupancy profiling libraries 1 and
estimate mapping of T–C transitions to lincRNAs [46].rate bedgraph file for each strand (Watson/Crick). Additionally, a
single bedgraph file for strand-specific T–C conversions is pro-
duced in a similar manner. T–C transition sites are only included
in the final file if at least two transitions from independent reads
are observed on average. Bedgraph files can be conveniently loaded
into UCSC hg18 genome browser for visualization purposes. Fig. 5B
shows the distribution of sequence normalized T–C transition
event counts mapping to different exonic transcript regions as well
as introns, lincRNAs [46] and ncRNAs for two occupancy profiling
libraries (also see Supplementary Table S2).
To streamline the described analysis process, we have devel-
oped ‘‘poppi’’, the protein occupancy profiling pipeline (unpub-
lished). Poppi performs all the described analysis steps and
allows quality assessment of protein occupancy profiling experi-
ments including screening of the diagnostic T–C transition counts.
In addition, it allows the correlation of protein occupancy profiles
to annotated features, between replicates as well as between dif-
ferent experimental conditions to define significant local changes
in protein occupancy. Figs. 6A–C exemplify protein occupancy pro-
files on polyadenylated mRNA and lincRNA for biological replicate
experiments performed in HEK293 cells. In Fig. 6A, the genomic re-
gion encoding the full length EEF2 transcript is visualized. Fig. 6B
shows a zoom-in to the 30UTR region of EEF2. The HEK293 occu-
pancy profile of the long intervening noncoding RNA DANCR (also
known as ANCR or KIAA0114), which is required to maintain the
undifferentiated state in human somatic tissue progenitor cells
[47] is shown in Fig. 6C.3. Concluding remarks
The broad discovery and characterization of protein binding
sites on RNA that control distinct posttranscriptional processes
was facilitated by application of various CLIP based approaches
to comprehensively map protein–RNA interaction sites. However,
until now all available methods focus only on the binding specific-
ity of individual RNA-binding proteins [32–34]. Protein occupancy
profiling provides a snapshot view of all protein–RNA interactions
occurring in a transcriptome at a given time without limiting the
captured interactions to a specific RBP. Thus investigators can
now take the sequence space of potential cis-regulatory elements
into consideration and monitor differential changes in protein
occupancy on specific transcript regions in response to intra- and
extracellular signals or stimuli. Importantly such studies can be
performed in an unbiased manner, without prior knowledge ofon of T–C transitions to different transcript and genomic regions. (A) Percentage of
ancy profiling data. T–C transition frequency of 4SU labeled and crosslinked RNA
s detected in non-crosslinked 4SU labeled RNA represent 5% of the T–C transition
nt crosslinking of 4SU-labeled RNA to protein. (B) Distribution of T–C transitions to
2. The human lincRNA catalog published by Cabili et al. was used as reference to
Fig. 6. Browser view of protein occupancy profiles on mRNA and lincRNA. (A) Browser view of genomic region encoding full length EEF2 transcript. Protein–RNA crosslinking
events represented by diagnostic T–C transitions are shown in black, as consensus T–C transition profile. Sequence coverage is shown in orange, PhyloP mammalian
conservation score is indicated in green. (B) As in (A), but zoom-in to 30UTR of EEF2 transcript is shown. Diagnostic T–C transitions are shown as individual T–C transition
profiles obtained from biological replicate experiments (libraries 1 and 2, respectively). (C) As in (A), but genomic region encoding the long noncoding RNA DANCR (also
known as ANCR or KIAA0114) is shown.
308 M. Munschauer et al. /Methods 65 (2014) 302–309the protein component mediating the observed effects. By using
oligo (dT) affinity purification of RNA, the dynamics in protein
occupancy can readily be captured for protein coding transcripts
as well as many lincRNAs. Global mapping of protein–RNA contact
sites on lincRNAs can provide insights into the postulated modular
design of these noncoding RNAs and determine the individual lin-
cRNA–protein interaction domains. Such research can shed valu-
able light on the fascinating question of how lincRNAs are
functionally assembled and how they interact with various protein
components to mediate their regulatory tasks.
Protein occupancy profiling makes use of a diagnostic mutation
signature present in 4SU labeled RNA that is crosslinked to pro-
teins in binding distance. It is important to note that the presence
or absence of the diagnostic mutation in sequence reads is used to
separate crosslinking signal from background noise. Efficient label-
ing of cellular RNA with 4SU is essential to the success of the
experiment and might require optimization. Use of stringent and
partly denaturing mRNA purification conditions ensure specific
isolation of directly interacting protein–RNA complexes, while
RNase I is used for generation of protein protected RNA fragments
without nucleotide bias. Protein precipitation by ammonium sul-
fate and transfer of separated complexes onto nitrocellulose are
key steps towards the reduction of free RNA and ensure high signal
to noise ratios when comparing T–C containing versus perfect
matching reads (Fig. 5A).
In the future a central task will be to overlap occupied regions
with evolutionary constrained sequences and RNA candidate struc-
tures [48] as well as with RNA interaction data of individual pro-
teins [49] to identify specific RNA regulatory elements and their
structural contexts. Capturing the dynamics in protein occupancyon functional RNA elements holds potential to reveal unappreci-
ated aspects of how posttranscriptional gene regulation contrib-
utes to complex biological processes in developmental or disease.
In addition, we envision the identification of differentially occu-
pied mRNA sites to be highly valuable towards the examination
of rapidly emerging data on genetic variation between individuals.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.ymeth.2013.
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